GENE ONLINE|News &
Opinion
Blog

Feature
Indian CDMO Stocks in the Spotlight: US House to Vote on BIOSECURE Act Next Week
2024-09-06
Eli Lilly Joins Forces with AI Startup Genetic Leap in $409M Deal Centered Around RNA-Targeted Drug Discovery
2024-09-06
Breaking New Ground for Clinical Trials with AI/ML Applications
2024-09-05
AusBiotech on Funding, Regulatory Navigation, International Expansion, and Clinical Trial Development in Australia’s Biotech Industry
2024-08-22
Early Regulatory Engagement – The Key to Fast-Tracking Nucleic Acid Drug Development
2024-08-22
BIO Asia-Taiwan’s CGT Vax Discovery Symposium—Collaborations, Innovations and Emerging Tech in Taiwan’s Vaccine Industry
2024-08-19
Lykos Wraps Up Turbulent Week with 75% Staff Cuts Following FDA Rejection and Publication Retractions
2024-08-16
Africa CDC Declares First-Ever Public Health Emergency Amid Escalating Mpox Outbreak
2024-08-14
Reshaping the Genetic Testing Landscape with Quantum Computing: Dr. Anmol Kapoor, CEO of BioAro
2024-08-13
ROR1 in Focus as a target for ADC-based treatments: Recent Developments and Industry Challenges – Part III
2024-08-07
Experts Advocate for Increased Incentives and Cost Reduction for Biosimilar Prescriptions at Asian Biotechnology Exhibition
2024-08-05
Investment Summit Highlights: Advancements in Therapeutics & Pharmaceuticals
2024-08-02
NMT Inhibitors and Next-Gen Nectin-4 ADCs a Field Ripe for Research – Part II
2024-08-01
Protect Animal Health and DotBio Announce Collaboration to Develop Advanced Therapies and Technologies for Canine and Feline Health
2024-07-30
Shaping the Future of Digital Health in Asia-Pacific Region
2024-07-27
1 2 3 63
LATEST
Lotus Pharma Expands in Southeast Asia with Alpha Choay Acquisition from Sanofi
2024-09-06
Eli Lilly Joins Forces with AI Startup Genetic Leap in $409M Deal Centered Around RNA-Targeted Drug Discovery
2024-09-06
Illumina Wins EU Court Battle, Dodges Fine, but Grail Deal Already Void
2024-09-05
Breaking New Ground for Clinical Trials with AI/ML Applications
2024-09-05
InMed Pharmaceuticals’ Positive Market Response to Cannabinoid Analog INM-901 for Alzheimer’s Treatment
2024-09-04
Alnylam Pharma Shares Dip Despite Positive Phase 3 HELIOS-B Heart Disease Results
2024-09-04
ESMO Introduces New Framework for Evaluating Tumor-Agnostic Potential of Cancer Treatments
2024-09-03
EVENT
2024-09-11
2024 Bio Asia Pacific
Bangkok, Thailand
2024-09-13
ESMO Congress 2024
Barcelona, Spain
2024-10-09
Medical Japan 2024 Tokyo
Tokyo, Japan
2024-10-15
BIO Investor Forum 2024
San Francisco, U.S.A.
Scroll to Top